| Status |
Description | Section |
| RED | Potassium Chloride and Sodium Chloride Intravenous Infusion | Nutrition and blood, Intravenous potassium, 09.02.02.01 |
| RED | Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion | Nutrition and blood, Intravenous potassium, 09.02.02.01 |
| GREEN | Sodium Chloride Slow Sodium® | Nutrition and blood, Oral sodium and water, 09.02.01.02 |
| GREEN | Sodium Chloride | Respiratory system, Nebuliser Diluent, 03.01.05 |
| GREEN | sodium chloride 0.9% (Nasal drops) | Ear, nose and oropharynx, Topical nasal decongestants, 12.02.02 |
| RED | Sodium Chloride 1mmol/1mL (Oral Solution) | Nutrition and blood, Oral sodium and water, 09.02.01.02 |
| Amber SPA | Sodium chloride 3% and 6% (Hypertonic) | Respiratory system, Hypertonic Sodium Chloride, 03.07 |
| RED | Sodium Chloride 30% (5mmol/ml) (Oral Solution) | Nutrition and blood, Oral sodium and water, 09.02.01.02 |
| GREEN | Sodium Chloride 5% eye products | Eye, Tear deficiency, ocular lubricants, and astringents, 11.08.01 |
| Amber SPA | Sodium chloride 7% (Hypertonic) | Respiratory system, Hypertonic Sodium Chloride, 03.07 |
| RED | Sodium Chloride and Glucose Intravenous Infusion | Nutrition and blood, Intravenous sodium, 09.02.02.01 |
| RED | Sodium Chloride Intravenous | Nutrition and blood, Intravenous sodium, 09.02.02.01 |
| RED | Acetylcysteine 2g/10mL (nebulised) | Respiratory system, Mucolytics, 03.07 |
| RED | Adrenaline / epinephrine 1 in 1,000 | Respiratory system, Anaphylaxis, 03.04.03 |
| RED | Bendamustine | Malignant disease and immunosuppression, Alkylating drugs, 08.01.01 |
| RED | Bleomycin | Malignant disease and immunosuppression, Anthracyclines and other cytotoxic antibiotics, 08.01.02 |
| RED | Bortezomib Velcade® | Malignant disease and immunosuppression, Bortezomib, 08.01.05 |
| RED | Cetuximab Erbitux® | Malignant disease and immunosuppression, Cetuximab, 08.01.05 |
| RED | Cisplatin | Malignant disease and immunosuppression, Platinum compounds, 08.01.05 |
| RED | Docetaxel Taxotere® | Malignant disease and immunosuppression, Taxanes, 08.01.05 |
| RED | Doxycycline 100mg/5mL (Injection) | Infections, Tetracyclines, 05.01.03 |
| RED | Etoposide | Malignant disease and immunosuppression, Vinca alkaloids and etoposide, 08.01.04 |
| RED | Gemcitabine Gemzar® | Malignant disease and immunosuppression, Antimetabolites, 08.01.03 |
| RED | Heparin sodium | Cardiovascular system, Heparin, 02.08.01 |
| Amber SPA | Heparin sodium 200units / 2mL (Line patency) | Cardiovascular system, Heparin flushes, 02.08.01 |
| Amber SPA | Heparin sodium 50units/5mL (Line patency) | Cardiovascular system, Heparin flushes, 02.08.01 |
| RED | Mitomycin | Malignant disease and immunosuppression, Anthracyclines and other cytotoxic antibiotics, 08.01.02 |
| RED | Mitoxantrone (Mitozantrone) | Malignant disease and immunosuppression, Anthracyclines and other cytotoxic antibiotics, 08.01.02 |
| RED | Natalizumab Tysabri® | Malignant disease and immunosuppression, Natalizumab, 08.02.04 |
| RED | Pentostatin Nipent® | Malignant disease and immunosuppression, Pentostatin, 08.01.05 |
| RED | Pixantrone | Malignant disease and immunosuppression, Anthracyclines and other cytotoxic antibiotics, 08.01.02 |
| RED | Raltitrexed Tomudex® | Malignant disease and immunosuppression, Antimetabolites, 08.01.03 |
| RED | Trastuzumab Herceptin® | Malignant disease and immunosuppression, Trastuzumab, 08.01.05 |
| RED | Urokinase | Cardiovascular system, Fibrinolytic drugs, 02.10.02 |
| RED | Vinblastine Sulphate | Malignant disease and immunosuppression, Vinca alkaloids and etoposide, 08.01.04 |
| RED | Vincristine Sulphate | Malignant disease and immunosuppression, Vinca alkaloids and etoposide, 08.01.04 |
| RED | Vinorelbine | Malignant disease and immunosuppression, Vinca alkaloids and etoposide, 08.01.04 |